Blood was tested for the presence of any remaining cancer cells using the clonoSEQ ... of Autologous Hematopoietic Cell Transplantation (auto-HCT) in Mantle Cell Lymphoma (MCL) Patients (pts ...

The first patient with relapsed or refractory CD5-positive T-cell lymphoma has been dosed with the CAR-T cell therapy MB-105.

Diffuse large B-cell lymphoma (DLBCL) is the most common and fast-growing type of non-Hodgkin lymphoma, a cancer that affects ...

after the CHMP backed its KTE-X19 therapy for mantle cell lymphoma. The EMA’s human drugs advisory committee recommended approval of KTE-X19 (autologous anti-CD19-transduced CD3+ cells ...

that assesses diagnostic technologies through its Molecular Diagnostic Services Program (MolDX), has expanded coverage of clonoSEQ ® to include single time point testing to monitor for recurrence in ...

Mantle Cell Lymphoma (MCL) and Follicular Lymphoma (FL): Rare but challenging cancers. • Multiple Myeloma (MM): A cancer of plasma cells in the bone marrow. Benefits of CAR T-Cell Therapy Over ...

Roche has secured approval from the EC for Columvi plus GemOx combo to treat adults with R/R diffuse large B-cell lymphoma ...

clonoSEQ testing for patients with diffuse large B-cell lymphoma (DLBCL ... and quantify specific DNA sequences found in malignant cells, allowing clinicians to assess and monitor MRD during ...